The researchers in this study indicated that PTX3 was an independent risk factor of HCC and helped to distinguish HCC from chronic HBV infection, not only in advanced stages, but also in the initial stages, as well as in those patients whose AFP (alpha fetoprotein) levels were negative. The gene discussed is PTX3; the disease is hepatocellular carcinoma.